MAPT and Cognitive impairment: Deficiency of DAP12 in tauopathy PS19 and amyloidogenic APP/PS1 mice alleviates cognitive impairment via attenuating the C1q-CR3 complement pathway despite increased tau pathology and diffused Aβ plaques, respectively [135,136,137].